Nektar Therapeutics (NKTR) Posts Q2 EPS Loss of $0.32, Revenues 60% Y/Y
Go back to Nektar Therapeutics (NKTR) Posts Q2 EPS Loss of $0.32, Revenues 60% Y/Y| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 73.68 -2.24 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.92 | 52 Week High | $19.98 | |||
| Open | $74.00 | 52 Week Low | $10.52 | |||
| Day High | $75.75 | P/E | N/A | |||
| Day Low | $72.05 | EPS | $-1.45 | |||
| Volume | 499,416 | |||||
